Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status (Q37634350)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 2009

edit

Language	Label	Description	Also known as
English	Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status	scientific article published on October 2009

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19921118

retrieved

21 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19921118

retrieved

21 August 2017

main subject

steatohepatitis

0 references

preproinsulin

1 reference

based on heuristic

inferred from title

fatty liver disease

0 references

liver disease

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

author

Lance L Stein

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

6659744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6659744&resulttype=core&format=json

retrieved

15 May 2020

author name string

Mamie H Dong

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

6659744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6659744&resulttype=core&format=json

retrieved

15 May 2020

Rohit Loomba

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

6659744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6659744&resulttype=core&format=json

retrieved

15 May 2020

language of work or name

English

0 references

publication date

1 October 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19921118

retrieved

21 August 2017

published in

Advances in Therapy

1 reference

stated in

Europe PubMed Central

PMC publication ID

6659744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6659744&resulttype=core&format=json

retrieved

15 May 2020

volume

26

1 reference

stated in

Europe PubMed Central

PMC publication ID

6659744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6659744&resulttype=core&format=json

retrieved

15 May 2020

issue

10

1 reference

stated in

Europe PubMed Central

PMC publication ID

6659744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6659744&resulttype=core&format=json

retrieved

15 May 2020

page(s)

893-907

1 reference

stated in

Europe PubMed Central

PMC publication ID

6659744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6659744&resulttype=core&format=json

retrieved

15 May 2020

cites work

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS12325-009-0072-Z

retrieved

21 January 2018

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS12325-009-0072-Z

retrieved

21 January 2018

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS12325-009-0072-Z

retrieved

21 January 2018

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin reverses fatty liver disease in obese, leptin-deficient mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin in non-alcoholic steatohepatitis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevalence and etiology of elevated aminotransferase levels in the United States

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin in the treatment of patients with non-alcoholic steatohepatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incretin mimetics as a novel therapeutic option for hepatic steatosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and effectiveness of rosiglitazone in type 2 diabetes patients with nonalcoholic Fatty liver disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PPAR delta as a therapeutic target in metabolic disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The obesity epidemic: pharmacological challenges

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The endocannabinoid system and the control of glucose homeostasis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PPARdelta agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dissecting insulin signaling pathways: individualised therapeutic targets for diagnosis and treatment of insulin resistant states

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones and fractures in men and women

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steatohepatitis: a tale of two "hits"?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19921118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S12325-009-0072-Z

1 reference

stated in

Europe PubMed Central

PMC publication ID

6659744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6659744&resulttype=core&format=json

retrieved

15 May 2020

PMC publication ID

6659744

1 reference

stated in

Europe PubMed Central

PMC publication ID

6659744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6659744&resulttype=core&format=json

retrieved

15 May 2020

PubMed publication ID

19921118

1 reference

stated in

Europe PubMed Central

PMC publication ID

6659744

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6659744&resulttype=core&format=json

retrieved

15 May 2020

ResearchGate publication ID

38096882

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37634350&oldid=2234659029"